| |
|
Form Serial Number: |
DA20201204E00314
|
| 1.
Date of relevant event: |
25/11/2020
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
01/12/2020
(dd/mm/yyyy)
|
| 3.
Stock code: |
06855 |
| 4.
Name of listed corporation: |
Ascentage Pharma Group International - B |
| 5.
Class of shares: |
Ordinary Shares |
| 6.
Number of issued shares in class: |
224,299,727 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
Guo |
| (Other names) |
Edward Ming |
|
|
|
| 10.
Name of director (Chinese): |
郭明 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1710 | Miscellaneous
Voluntary disclosure (you must briefly describe the relevant event in the Supplementary Information box) |
|
|
|
|
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 67,204,967 | 30.01 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 67,204,967 | 29.96 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| 2501 | Other (you must describe the capacity in the Supplementary Information box) |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| Ascentage Limited | Woodbourne Hall, Road Town, Tortola, British Virgin Islands | Guo Edward Ming | 27.69 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| Yang Dajun | Addresses of individuals are not displayed. | |
| Zhai Yifan | Addresses of individuals are not displayed. | |
| Wang Xiaomeng | Addresses of individuals are not displayed. | |
| Ascentage Limited | Addresses of individuals are not displayed. | |
| HealthQuest Pharma Limited | Addresses of individuals are not displayed. | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| Ming Edward Guo Dynasty Trust | Addresses of individuals are not displayed. | | 5103 | Founder of a discretionary trust who can influence how the trustee exercises his discretion |
| |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
Guo Edward Ming held his interests in box 26 jointly with other persons, through interests in controlled corporation and as a founder of a trust. The number of the issued shares of the Company was increased from 223,901,727 to 224,299,727 due to issuance of an aggregate of 398,000 shares upon exercise of share options. For details, please refer to the next day disclosure return of the Company dated 25 November 2020.
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
04/12/2020
(dd/mm/yyyy)
|
| |